Momesonex (Mometasone Furoate)

Mometasone furoate, the active ingredient in Momesonex, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis and nasal polyps in appropriate patient populations. GNH USA supplies Momesonex as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Momesonex is a nasal corticosteroid that acts on inflammatory processes of the nasal mucosa. - Allergic rhinitis: reduces nasal congestion, sneezing, itching and rhinorrhea. - Nasal polyps: decreases polyp size and improves nasal airflow. - Seasonal allergic rhinitis: alleviates symptoms triggered by seasonal allergens.

Momesonex may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation - Epistaxis (nosebleeds) - Headache - Throat irritation or dryness - Cough - Altered taste or bitter taste

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Vision changes or cataract formation - Adrenal suppression with systemic exposure - Opportunistic fungal infection of the nasal passages

Before using Momesonex, consider the following precautions. - Pediatric use: follow age‑specific dosing recommendations. - Active nasal infection: avoid until infection resolved. - Glaucoma or cataract: monitor intra‑ocular pressure. - Concomitant nasal steroids: do not use multiple nasal corticosteroids simultaneously. - Systemic corticosteroid therapy: assess risk of systemic effects. - Store at room temperature: keep in the original container, protect from moisture and heat.

Momesonex may interact with other medicines.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise local drug exposure. - Live vaccines: potential reduction in vaccine efficacy.

Moderate Interactions (Monitor Closely): - Azole antifungals (e.g., fluconazole): may modestly increase exposure. - Ritonavir or other potent CYP3A4 inhibitors: monitor for local irritation. - Nasal decongestants (e.g., oxymetazoline): may increase nasal irritation.